Metabolic Hallmarks of Malignant Cells
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".
Deadline for manuscript submissions: closed (1 July 2023) | Viewed by 2021
Special Issue Editors
Interests: metabolism in cancer; metabolic therapies; metabolic imaging; metabolic phenotypes; mitochondria metabolism in oncology
Interests: metabolism in cancer; metabolic therapies; metabolic imaging; metabolic phenotypes; mitochondria metabolism in oncology
Special Issue Information
Dear Colleagues,
Changes in cellular metabolism are a hallmark of malignancy and are therefore fundamental to oncology. However, cellular metabolism is dynamic, with multiple pathways feeding each other to generate both small molecules and large macromolecules. Therefore, understanding and targeting metabolism is a difficult endeavor. The aim of the Special Issue is to discuss unique metabolic phenotypes in oncology, how these phenotypes are being translated into clinical treatments, how in vivo imaging can be used interrogate metabolism, and the correlation between metabolism and immune therapy.
Cancers is in the process of generating a Special Issue focused on Metabolic Hallmarks of Malignant Cells. As leaders in the field, you will be aware of the importance of metabolism in oncology. Changes in cellular metabolism are a hallmark of cancer, but due to its dynamic nature and the dual role of catabolism and anabolism, understanding and targeting metabolism is a difficult endeavor. The aim of the Special Issue is to discuss unique metabolic phenotypes in oncology, how these phenotypes are being translated into clinical treatments, how in vivo imaging can be used interrogate metabolism, and the correlation between metabolism and immune therapy. We are pleased to invite you to contribute original research articles, reviews, or perspectives based on this topic. We look forward to receiving your contributions.
Dr. Niki M. Zacharias Millward
Dr. Pavlos Msaouel
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- metabolism in cancer
- metabolic therapies
- metabolic imaging
- metabolic phenotypes
- mitochondria metabolism in oncology
